Astutemedical
2 known investors
bioMérieux develops in vitro diagnostic systems and molecular testing panels for pathogen detection in clinical, food safety, and pharmaceutical quality control settings. The company serves healthcare providers, laboratories, food industry, and pharmaceutical manufacturers with rapid PCR-based diagnostic solutions.
BiotechHealthtechMedical Devices